Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Women's acne improvement with antibiotics is not linked to signs of high male hormones.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Clascoterone cream could be used for other skin conditions affected by hormones.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

PCOS affects many women, causing hormonal issues and health risks, but can be managed with lifestyle changes and medication.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.